Physician profile

Daniel L Altchuler

Podiatrist · Santa Monica, CA

NPI 1518071745

$991.96

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$429.03

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Inari Medical, INC. $175.74 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Angiodynamics, INC. $164.49 2021-2022
Paragon 28, INC. $131.58 2023 Portfolio
Melinta Therapeutics, LLC $123.47 2022
Smith+Nephew, INC. $115.78 2019
Biotissue Holdings INC. $108.38 2023
Tei Medical INC. $69.44 2019
Integra Lifesciences Corporation $62.50 2019
Cardiovascular Systems INC. $27.25 2021
Treace Medical Concepts, INC. $13.33 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel L Altchuler

$991.96

in general payments reported 2019-2025

Years
2019-2024
Top company
Inari Medical, INC.

https://glasscript.com/doctor/577008/daniel-l-altchuler

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.